scholarly journals The Future of Adult Cardiac Assist Devices: Novel Systems and Mechanical Circulatory Support Strategies

2011 ◽  
Vol 29 (4) ◽  
pp. 559-582 ◽  
Author(s):  
Carlo R. Bartoli ◽  
Robert D. Dowling
ASAIO Journal ◽  
1996 ◽  
Vol 42 (2) ◽  
pp. 33
Author(s):  
V. Theodoridis ◽  
J. M??ller ◽  
Y-G. Weng ◽  
M. Loebe ◽  
S. Spiegelsberger ◽  
...  

ASAIO Journal ◽  
1996 ◽  
Vol 42 (2) ◽  
pp. 33 ◽  
Author(s):  
V. Theodoridis ◽  
J. Müller ◽  
Y-G. Weng ◽  
M. Loebe ◽  
S. Spiegelsberger ◽  
...  

2009 ◽  
Vol 3 (2) ◽  
Author(s):  
D. R. Trumble ◽  
M. Norris ◽  
G. Peters

Harnessing skeletal muscle for circulatory support would improve on current blood pump technologies by eliminating infection-prone drivelines and expensive transcutaneous transmission systems. Here we describe an implantable muscle energy converter (MEC) designed to transmit the contractile energy of the latissimus doris muscle in hydraulic form. The MEC weighs just 290 grams and comprises a metallic bellows actuated by a rotary arm fixed to the humeral insertion of the muscle via a looped artificial tendon. The housing is anchored to the ribcage using a perforated mounting ring (83 mm diameter). Lessons learned through six design iterations have produced a pump with excellent durability, energy transfer efficiency, anatomic fit, and tissue interface characteristics. This report describes recent improvements in MEC design and summarizes results from in silico, in vitro, and in vivo testing. The components most subject to wear in this device are the stainless-steel bellows, spring-loaded lip seals, and load-bearing surfaces (bearings, cams and shafts). Roller bearings supporting the camshaft and cam follower were replaced with needle bearings for better stress distribution and longer cycle life. Camshaft bearings were improved still further by changing to a full-complement configuration to lower stress concentration and reduce lateral (off-axis) shaft movement that could reduce lipseal life. Bellows cycle life was estimated using ANSYS V11 finite element analysis (FEA) software with a mesh size of 0.002”. In this simulation a pressure of 22 psi was applied to the internal surface of the bellows and compression length was set to the longest possible stroke (0.177”). All load-bearing surfaces were analyzed for fatigue stress and cycle life under these same loading conditions following closed form equations. Results show that the overall durability of the MEC device can be expected to exceed 450 million cycles, resulting in a minimum working life of 14.5 years given a 1 Hz cycle rate. Lipseal durability was tested empirically in a 37°C saline bath using a cycling apparatus designed specifically for that purpose. After 55 days (12.3 million cycles) the test was stopped and the unit disassembled and inspected. The shaft and seals showed evidence of contamination buildup in front of the lip seal but not behind it, indicating that the seal had functioned properly throughout the test period. Importantly, implant studies in 30–35 Kg dogs (n=7) confirm excellent anatomic fit, patient comfort, and device functionality to one month. These results suggest that muscle-powered cardiac assist devices are feasible and that efforts to further develop this technology are warranted.


2019 ◽  
Vol 6 (1) ◽  
pp. 18 ◽  
Author(s):  
Jooli Han ◽  
Dennis Trumble

Congestive heart failure (CHF) is a debilitating condition that afflicts tens of millions of people worldwide and is responsible for more deaths each year than all cancers combined. Because donor hearts for transplantation are in short supply, a safe and durable means of mechanical circulatory support could extend the lives and reduce the suffering of millions. But while the profusion of blood pumps available to clinicians in 2019 tend to work extremely well in the short term (hours to weeks/months), every long-term cardiac assist device on the market today is limited by the same two problems: infections caused by percutaneous drivelines and thrombotic events associated with the use of blood-contacting surfaces. A fundamental change in device design is needed to address both these problems and ultimately make a device that can support the heart indefinitely. Toward that end, several groups are currently developing devices without blood-contacting surfaces and/or extracorporeal power sources with the aim of providing a safe, tether-free means to support the failing heart over extended periods of time.


1988 ◽  
Vol 6 (3) ◽  
pp. 449-459 ◽  
Author(s):  
John A. Elefteriades

2008 ◽  
Vol 56 (S 1) ◽  
Author(s):  
M Petersen ◽  
N Guldner ◽  
M Großherr ◽  
HH Sievers

2021 ◽  
Vol 32 (4) ◽  
pp. 424-433
Author(s):  
Emalie Petersen

Heart failure is a leading cause of morbidity and mortality in the United States. Treatment of this condition increasingly involves mechanical circulatory support devices. Even with optimal medical therapy and use of simple cardiac devices, heart failure often leads to reduced quality of life and a shortened life span, prompting exploration of more advanced treatment approaches. Left ventricular assist devices constitute an effective alternative to cardiac transplantation. These devices are not without complications, however, and their use requires careful cooperative management by the patient’s cardiology team and primary care provider. Left ventricular assist devices have undergone many technological advancements since they were first introduced, and they will continue to evolve. This article reviews the history of different types of left ventricular assist devices, appropriate patient selection, and common complications in order to increase health professionals’ familiarity with these treatment options.


2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Sayed Nour ◽  
Jia Liu ◽  
Gang Dai ◽  
Daniel Carbognani ◽  
Daya Yang ◽  
...  

Cardiac assist devices (CAD) cause endothelial dysfunction with considerable morbidity. Employment of pulsatile CAD remains controversial due to inadequate perfusion curves and costs. Alternatively, we are proposing a new concept of pulsatile CAD based on a fundamental revision of the entire circulatory system in correspondence with the physiopathology and law of physics. It concerns a double lumen disposable tube device that could be adapted to conventional cardiopulmonary bypass (CPB) and/or CAD, for inducing a homogenous, downstream pulsatile perfusion mode with lower energy losses. In this study, the device’s prototypes were tested in a simulated conventional pediatric CPB circuit for energy losses and as a left ventricular assist device (LVAD) in ischemic piglets model for endothelial shear stress (ESS) evaluations. In conclusion and according to the study results the pulsatile tube was successfully capable of transforming a conventional CPB and/or CAD steady flow into a pulsatile perfusion mode, with nearly physiologic pulse pressure and lower energy losses. This represents a cost-effective promising method with low mortality and morbidity, especially in fragile cardiac patients.


Sign in / Sign up

Export Citation Format

Share Document